{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:03:44Z","timestamp":1793142224145,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00210-023-02829-3","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T13:02:13Z","timestamp":1699880533000},"page":"3411-3424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hederagenin protects against myocardial ischemia\u2013reperfusion injury via attenuating ALOX5-mediated ferroptosis"],"prefix":"10.1007","volume":"397","author":[{"given":"Li","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"issue":"3","key":"2829_CR1","doi-asserted-by":"publisher","first-page":"H659","DOI":"10.1152\/ajpheart.00452.2017","volume":"314","author":"Y Baba","year":"2018","unstructured":"Baba Y, Higa JK, Shimada BK, Horiuchi KM, Suhara T, Kobayashi M et al (2018) Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol 314(3):H659\u2013H68. https:\/\/doi.org\/10.1152\/ajpheart.00452.2017. (Epub 2017\/11\/12 PubMed PMID: 29127238; PubMed Central PMCID: PMCPMC5899260)","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2829_CR2","doi-asserted-by":"publisher","first-page":"165768","DOI":"10.1016\/j.bbadis.2020.165768","volume":"7","author":"H Bugger","year":"1866","unstructured":"Bugger H, Pfeil K (1866) 2020 Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis 7:165768. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165768. (Epub 2020\/03\/17 PubMed PMID: 32173461)","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"19","key":"2829_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai W, Liu L, Shi X, Liu Y, Wang J, Fang X et al (2023) Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation 147(19):1444\u201360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060257. (Epub 2023\/03\/30 PubMed PMID: 36987924)","journal-title":"Circulation"},{"issue":"11\u201312","key":"2829_CR4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73(11\u201312):2195\u2013209. https:\/\/doi.org\/10.1007\/s00018-016-2194-1. (Epub 2016\/04\/07 PubMed PMID: 27048822; PubMed Central PMCID: PMCPMC4887533)","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2829_CR5","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/fsn3.3163","volume":"11","author":"Y Dai","year":"2023","unstructured":"Dai Y, Masra N, Zhou L, Yu C, Jin W, Ni H (2023) Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study. Food Sci Nutr 11(3):1283\u201396. https:\/\/doi.org\/10.1002\/fsn3.3163. (Epub 2023\/03\/14 PubMed PMID: 36911825; PubMed Central PMCID: PMCPMC10002964)","journal-title":"Food Sci Nutr"},{"issue":"4","key":"2829_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1248\/bpb.b22-00174","volume":"46","author":"Y Ding","year":"2023","unstructured":"Ding Y, Li W, Peng S, Zhou G, Chen S, Wei Y et al (2023) Puerarin protects against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis. Biol Pharm Bull 46(4):524\u201332. https:\/\/doi.org\/10.1248\/bpb.b22-00174. (Epub 2023\/01\/26 PubMed PMID: 36696989)","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"2829_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17(12):773\u201389. https:\/\/doi.org\/10.1038\/s41569-020-0403-y. (Epub 2020\/07\/06 PubMed PMID: 32620851)","journal-title":"Nat Rev Cardiol"},{"key":"2829_CR8","doi-asserted-by":"publisher","first-page":"110122","DOI":"10.1016\/j.intimp.2023.110122","volume":"118","author":"J Jia","year":"2023","unstructured":"Jia J, Xu LH, Deng C, Zhong X, Xie KH, Han RY et al (2023) Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK\/STAT signaling. Int Immunopharmacol 118:110122. https:\/\/doi.org\/10.1016\/j.intimp.2023.110122. (Epub 2023\/04\/07 PubMed PMID: 37023701)","journal-title":"Int Immunopharmacol"},{"key":"2829_CR9","doi-asserted-by":"crossref","unstructured":"Jin ZL, Gao N Fau - Zhou D, Zhou D Fau - Chi M-G, Chi Mg Fau - Yang X-M, Yang Xm Fau - Xu J-P, Xu JP (2012) The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor. (1873\u20135177 (Electronic))","DOI":"10.1016\/j.pbb.2011.10.001"},{"issue":"45","key":"2829_CR10","doi-asserted-by":"publisher","first-page":"26238","DOI":"10.1039\/c9ra02043h","volume":"9","author":"Y Li","year":"2019","unstructured":"Li Y, Dong J, Shang Y, Zhao Q, Li P, Wu B (2019) Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-kappaB and Smads signaling pathways in a type-2 diabetic mice model. RSC Adv 9(45):26238\u201347. https:\/\/doi.org\/10.1039\/c9ra02043h. (Epub 2019\/08\/21 PubMed PMID: 35531007; PubMed Central PMCID: PMCPMC9070383)","journal-title":"RSC Adv"},{"issue":"2","key":"2829_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","volume":"39","author":"W Li","year":"2020","unstructured":"Li W, Li W, Leng Y, Xiong Y, Xia Z (2020) Ferroptosis is involved in diabetes myocardial ischemia\/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol. 39(2):210\u201325. https:\/\/doi.org\/10.1089\/dna.2019.5097. (Epub 2019\/12\/07 PubMed PMID: 31809190)","journal-title":"DNA Cell Biol."},{"key":"2829_CR12","doi-asserted-by":"publisher","first-page":"8917947","DOI":"10.1155\/2022\/8917947","volume":"2022","author":"M Li","year":"2022","unstructured":"Li M, Xin S, Gu R, Zheng L, Hu J, Zhang R et al (2022) Novel diagnostic biomarkers related to oxidative stress and macrophage ferroptosis in atherosclerosis. Oxid Med Cell Longev 2022:8917947. https:\/\/doi.org\/10.1155\/2022\/8917947. (Epub 2022\/08\/30 PubMed PMID: 36035208; PubMed Central PMCID: PMCPMC9410850)","journal-title":"Oxid Med Cell Longev"},{"key":"2829_CR13","doi-asserted-by":"publisher","first-page":"712876","DOI":"10.3389\/fphar.2021.712876","volume":"12","author":"R Lin","year":"2021","unstructured":"Lin R, Liu L, Silva M, Fang J, Zhou Z, Wang H et al (2021) Hederagenin protects PC12 Cells against corticosterone-induced injury by the activation of the PI3K\/AKT pathway. Front Pharmacol 12:712876. https:\/\/doi.org\/10.3389\/fphar.2021.712876. (Epub 2021\/11\/02 PubMed PMID: 34721013; PubMed Central PMCID: PMCPMC8551867)","journal-title":"Front Pharmacol"},{"key":"2829_CR14","doi-asserted-by":"publisher","first-page":"176031","DOI":"10.1016\/j.ejphar.2023.176031","volume":"957","author":"JH Lin","year":"2023","unstructured":"Lin JH, Yang KT, Ting PC, Lee WS, Lin DJ, Chang JC (2023) Licochalcone a improves cardiac functions after ischemia-reperfusion via reduction of ferroptosis in rats. Eur J Pharmacol 957:176031. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176031. (Epub 2023\/09\/04 PubMed PMID: 37660967)","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2829_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.18388\/abp.2009_2503","volume":"56","author":"OO Lisovyy","year":"2009","unstructured":"Lisovyy OO, Dosenko VE, Nagibin VS, Tumanovska LV, Korol MO, Surova OV et al (2009) Cardioprotective effect of 5-lipoxygenase gene (ALOX5) silencing in ischemia-reperfusion. Acta Biochim Pol 56(4):687\u2013694 (Epub 2009\/12\/17 PubMed PMID: 20011686)","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"2829_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/FJC.0000000000001199","volume":"79","author":"X Liu","year":"2021","unstructured":"Liu X, Qi K, Gong Y, Long X, Zhu S, Lu F et al (2021) Ferulic acid alleviates myocardial ischemia reperfusion injury via upregulating AMPKalpha2 expression-mediated ferroptosis depression. J Cardiovasc Pharmacol 79(4):489\u2013500. https:\/\/doi.org\/10.1097\/FJC.0000000000001199. (Epub 2021\/12\/23 PubMed PMID: 34935700; PubMed Central PMCID: PMCPMC8983949)","journal-title":"J Cardiovasc Pharmacol"},{"key":"2829_CR17","doi-asserted-by":"publisher","first-page":"175748","DOI":"10.1016\/j.ejphar.2023.175748","volume":"951","author":"S Liu","year":"2023","unstructured":"Liu S, Ren J, Liu S, Zhao X, Liu H, Zhou T et al (2023) Resveratrol inhibits autophagy against myocardial ischemia-reperfusion injury through the DJ-1\/MEKK1\/JNK pathway. Eur J Pharmacol 951:175748. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175748. (Epub 2023\/05\/07 PubMed PMID: 37149277)","journal-title":"Eur J Pharmacol"},{"key":"2829_CR18","doi-asserted-by":"publisher","unstructured":"Pan Y, Wang X, Liu X, Shen L, Chen Q, Shu Q. (2022) Targeting ferroptosis as a promising therapeutic strategy for ischemia-reperfusion injury. Antioxidants (Basel) 11(11): 2196. Epub 2022\/11\/12 https:\/\/doi.org\/10.3390\/antiox11112196. (PubMed PMID: 36358568; PubMed Central PMCID: PMCPMC9686892)","DOI":"10.3390\/antiox11112196"},{"key":"2829_CR19","unstructured":"Shen Y, Teng L, Qu Y, Huang Y, Peng Y, Tang M et al (2023) Hederagenin suppresses inflammation and cartilage degradation to ameliorate the progression of osteoarthritis: an in vivo and in vitro study. (1573\u20132576 (Electronic))"},{"key":"2829_CR20","doi-asserted-by":"publisher","first-page":"102706","DOI":"10.1016\/j.redox.2023.102706","volume":"62","author":"KN Shi","year":"2023","unstructured":"Shi KN, Li PB, Su HX, Gao J, Li HH (2023) MK-886 protects against cardiac ischaemia\/reperfusion injury by activating proteasome-Keap1-NRF2 signalling. Redox Biol 62:102706. https:\/\/doi.org\/10.1016\/j.redox.2023.102706. (Epub 2023\/04\/26 PubMed PMID: 37098317; PubMed Central PMCID: PMCPMC10149391)","journal-title":"Redox Biol"},{"issue":"5\u20136","key":"2829_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1101\/gad.350211.122","volume":"37","author":"S Song","year":"2023","unstructured":"Song S, Su Z, Kon N, Chu B, Li H, Jiang X et al (2023) ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington\u2019s disease. Genes Dev 37(5\u20136):204\u201317. https:\/\/doi.org\/10.1101\/gad.350211.122. (Epub 2023\/03\/16 PubMed PMID: 36921996; PubMed Central PMCID: PMCPMC10111862)","journal-title":"Genes Dev"},{"key":"2829_CR22","doi-asserted-by":"publisher","first-page":"2749173","DOI":"10.1155\/2019\/2749173","volume":"2019","author":"QY Sun","year":"2019","unstructured":"Sun QY, Zhou HH, Mao XY (2019) Emerging roles of 5-lipoxygenase phosphorylation in inflammation and cell death. Oxid Med Cell Longev 2019:2749173. https:\/\/doi.org\/10.1155\/2019\/2749173. (Epub 2019\/12\/25 PubMed PMID: 31871543; PubMed Central PMCID: PMCPMC6906800)","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"2829_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/ACO.0000000000000981","volume":"34","author":"W Szczeklik","year":"2021","unstructured":"Szczeklik W, Fronczek J (2021) Myocardial injury after noncardiac surgery - an update. Curr Opin Anaesthesiol 34(3):381\u20136. https:\/\/doi.org\/10.1097\/ACO.0000000000000981. (Epub 2021\/05\/04 PubMed PMID: 33935187)","journal-title":"Curr Opin Anaesthesiol"},{"key":"2829_CR24","doi-asserted-by":"publisher","first-page":"117336","DOI":"10.1016\/j.lfs.2020.117336","volume":"244","author":"K Tian","year":"2020","unstructured":"Tian K, Su Y, Ding J, Wang D, Zhan Y, Li Y et al (2020) Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption. Life Sci 244:117336. https:\/\/doi.org\/10.1016\/j.lfs.2020.117336. (Epub 2020\/01\/24 PubMed PMID: 31972206)","journal-title":"Life Sci"},{"issue":"2","key":"2829_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334. (Epub 2009\/06\/06 PubMed PMID: 19499576; PubMed Central PMCID: PMCPMC3041641)","journal-title":"J Comput Chem"},{"issue":"8","key":"2829_CR26","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS et al (2022) Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 145(8):e153\u2013e639. https:\/\/doi.org\/10.1161\/CIR.0000000000001052. (Epub 2022\/01\/27 PubMed PMID: 35078371)","journal-title":"Circulation"},{"issue":"1","key":"2829_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/med.21817","volume":"42","author":"QZ Tuo","year":"2022","unstructured":"Tuo QZ, Zhang ST, Lei P (2022) Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev 42(1):259\u2013305. https:\/\/doi.org\/10.1002\/med.21817. (Epub 2021\/05\/07 PubMed PMID: 33957000)","journal-title":"Med Res Rev"},{"key":"2829_CR28","doi-asserted-by":"publisher","first-page":"154711","DOI":"10.1016\/j.phymed.2023.154711","volume":"112","author":"ZS Xie","year":"2023","unstructured":"Xie ZS, Zhao JP, Wu LM, Chu S, Cui ZH, Sun YR et al (2023) Hederagenin improves Alzheimer\u2019s disease through PPARalpha\/TFEB-mediated autophagy. Phytomedicine 112:154711. https:\/\/doi.org\/10.1016\/j.phymed.2023.154711. (Epub 2023\/02\/23 PubMed PMID: 36809694)","journal-title":"Phytomedicine"},{"key":"2829_CR29","doi-asserted-by":"crossref","unstructured":"Xie KH, Liu XH, Jia J, Zhong X, Han RY, Tan RZ et al (2022) Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik\/Axin2\/\u03b2-catenin signalling pathway. (1878\u20131705 (Electronic))","DOI":"10.1016\/j.intimp.2022.109247"},{"issue":"3","key":"2829_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.24272\/j.issn.2095-8137.2020.042","volume":"41","author":"HF Yan","year":"2020","unstructured":"Yan HF, Tuo QZ, Yin QZ, Lei P (2020) The pathological role of ferroptosis in ischemia\/reperfusion-related injury. Zool Res 41(3):220\u201330. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2020.042. (Epub 2020\/04\/22 PubMed PMID: 32314558; PubMed Central PMCID: PMCPMC7231469)","journal-title":"Zool Res"},{"key":"2829_CR31","doi-asserted-by":"publisher","unstructured":"Yao Y, Lin L, Tang W, Shen Y, Chen F, Li N et al (2023) Pretreatment with geniposide mitigates myocardial ischemia\/reperfusion injury by modulating inflammatory response through TLR4\/NF-\u03baB pathway. LID - https:\/\/doi.org\/10.4081\/ejh.2023.3742LID - 3742. (2038\u20138306 (Electronic))","DOI":"10.4081\/ejh.2023.3742"},{"key":"2829_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3389\/fphar.2020.01173","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu H, Song L, Cao X, Li W, Zhao Y, Chen J et al (2020) Hederagenin attenuates cerebral ischaemia\/reperfusion injury by regulating MLK3 signalling. Front Pharmacol 11:1173. https:\/\/doi.org\/10.3389\/fphar.2020.01173. (Epub 2020\/08\/28 PubMed PMID: 32848779; PubMed Central PMCID: PMCPMC7406912)","journal-title":"Front Pharmacol"},{"issue":"43","key":"2829_CR33","doi-asserted-by":"publisher","first-page":"24188","DOI":"10.1039\/c8ra03666g","volume":"8","author":"J Zeng","year":"2018","unstructured":"Zeng J, Huang T, Xue M, Chen J, Feng L, Du R et al (2018) Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review. RSC Adv 8(43):24188\u2013202. https:\/\/doi.org\/10.1039\/c8ra03666g. (Epub 2018\/07\/03 PubMed PMID: 35539158; PubMed Central PMCID: PMCPMC9082113)","journal-title":"RSC Adv"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02829-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:20:51Z","timestamp":1714990851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02829-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2829"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02829-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}